Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children

    Access Status
    Open access via publisher
    Authors
    Irani, V.
    Ramsland, Paul
    Guy, A.
    Siba, P.
    Mueller, I.
    Richards, J.
    Beeson, J.
    Date
    2015
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Irani, V. and Ramsland, P. and Guy, A. and Siba, P. and Mueller, I. and Richards, J. and Beeson, J. 2015. Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children. Clinical Infectious Diseases. 61 (8): pp. 1244-1252.
    Source Title
    Clinical Infectious Diseases
    DOI
    10.1093/cid/civ525
    ISSN
    1058-4838
    School
    School of Biomedical Sciences
    URI
    http://hdl.handle.net/20.500.11937/47326
    Collection
    • Curtin Research Publications
    Abstract

    Background: The targets and mechanisms of human immunity to malaria are poorly understood, which poses a major barrier to malaria vaccine development. Antibodies play a key role in human immunity and may act by inhibiting receptor-binding functions of key merozoite invasion ligands. Antibodies to the major invasion ligand and vaccine candidate, erythrocyte-binding antigen 175 (EBA-175), have been linked with protection, but how these antibodies function has not been established. Methods: We developed 2 new assays that quantify the ability of antibodies to inhibit binding of EBA-175 to its erythrocyte receptor, glycophorin A, using either native or recombinant EBA-175. Binding-inhibitory antibodies were evaluated in a longitudinal cohort study of Papua New Guinean children and related to risk of malaria, age, infection status, and markers of parasite exposure. Results: Binding-inhibition assays (BIAs) were reproducible, and the 2 assays had a high level of agreement. Inhibitory antibodies were common among children, acquired in association with markers of increasing parasite exposure, and high in those children with active infection. Inhibitory antibodies correlated with total immunoglobulin G levels to the EBA-175 binding domain (region II). Importantly, binding-inhibitory antibodies were significantly associated with protection from symptomatic malaria when measured using either BIA. Conclusions: Findings suggest that naturally acquired binding-inhibitory antibodies are an important functional mechanism that contributes to protection against malaria and further supports the potential of EBA-175 as a vaccine candidate. Identifying vaccines and approaches that induce potent binding-inhibitory antibodies may be a valuable strategy in the development of highly efficacious malaria vaccines.

    Related items

    Showing items related by title, author, creator and subject.

    • Otitis-prone children produce functional antibodies to pneumolysin and pneumococcal polysaccharides
      Kirkham, L.; Wiertsema, S.; Corscadden, K.; Mateus, T.; Mullaney, G.; Zhang, Guicheng; Richmond, P.; Thornton, R. (2017)
      Copyright © 2017 Kirkham et al. The pneumococcus is a major otitis media (OM) pathogen, but data are conflicting regarding whether otitis-prone children have impaired humoral immunity to pneumococcal antigens. We and ...
    • CD46 measles virus receptor polymorphisms influence receptor protein expression and primary measles vaccine responses in naive australian children
      Clifford, H.; Hayden, C.; Khoo, S.; Zhang, Guicheng; Le Souëf, P.; Richmonda, P. (2012)
      Despite the availability of measles vaccines, infants continue to die from measles. Measles vaccine responses vary between individuals, and poor immunogenicity is likely to preclude protection against measles. CD46 is a ...
    • Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India
      Ochiai, R.; Khan, M.; Soofi, S.; Sur, D.; Kanungo, S.; You, Y.; Habib, M.; Sahito, S.; Manna, B.; Dutta, S.; Acosta, C.; Ali, Mohammed; Bhattacharya, S.; Bhutta, Z.; Clemens, J. (2014)
      The geometric mean concentration (GMC) and the proportion maintaining a protective level (150 enzyme-linked immunosorbent assay (ELISA) units [ELU]/ml) 2 years following a single dose of 25 µg of injectable Vi capsular ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.